http://orcid.org/0000-0001-5553-7567
REFERENCES
- Cwik, B. 2020. Revising, correcting, and transferring genes. American Journal of Bioethics 20(8): 7–18.
- Erler, A. 2017. The Limits of the Treatment-Enhancement distinction as a guide to public policy. Bioethics 31(8):608–615. doi:10.1111/bioe.12377.
- Juengst, E. T. 2017. Crowdsourcing the moral limits of human gene editing? The Hastings Center Report 47(3):15–23. doi:10.1002/hast.701.
- National Academies of Science, Engineering, and Medicine. 2017. Human genome editing: Science, ethics, and governance. Washington, DC.
- Regalado, A. 2019. China’s CRISPR Twins Might Have Had Their Brains Inadvertently Enhanced. MIT Technology Review, February 21.
- Wolbring, G., L. Diep, S. Yumakulov, N. Ball, V. Leopatra, and D. Yergens. 2013. Emerging therapeutic enhancement enabling health technologies and their discourses: What is discussed within the health domain? Healthcare 1(1):20–52. doi:10.3390/healthcare1010020.